The Effect of the Ketogenic Diet on the Vascular Structure and Functions in Children With Intractable Epilepsy

Rahmi Özdemir1, Orkide Güzel2, Mehmet Küçük1

  • 1Department of Pediatric Cardiology, Izmir Dr. Behcet Uz Children's Hospital, Izmir, Turkey.

Pediatric Neurology
|January 18, 2016
PubMed

Insights

The ketogenic diet showed no adverse effects on blood vessel elasticity in children with epilepsy. However, it was associated with increased serum lipid levels after 12 months.

Area of Science:

  • Neurology
  • Cardiology
  • Pediatrics

Background:

  • Intractable epilepsy often requires alternative treatment strategies.
  • The ketogenic diet is a recognized therapy for drug-resistant epilepsy in children.
  • Potential effects of the ketogenic diet on cardiovascular health require investigation.

Purpose of the Study:

  • To assess the midterm impact of a ketogenic diet on serum lipid profiles.
  • To evaluate changes in carotid intima-media thickness and aortic/carotid elastic properties.
  • To determine the safety of the ketogenic diet concerning vascular health in pediatric epilepsy.

Main Methods:

  • Prospective study of 52 children (12 months–18 years) with intractable epilepsy on a ketogenic diet.
  • Echocardiography used to measure carotid intima-media thickness and elastic properties before and after 12 months of diet.
  • Seizure frequency and serum lipid levels were monitored.

Main Results:

  • Significant increases in total cholesterol, LDL, and triglycerides observed after 12 months.
  • No significant changes in HDL levels.
  • Carotid intima-media thickness, aortic/carotid strain, stiffness index, distensibility, and elastic modulus remained unchanged.
  • Seizure freedom achieved in 21 patients by 3 months and 25 by 1 year.

Conclusions:

  • An olive oil-based ketogenic diet does not appear to negatively affect carotid artery or aorta elasticity in epileptic children.
  • The diet may lead to elevated serum lipid concentrations.
  • Further monitoring of lipid profiles is warranted in pediatric patients on ketogenic diets.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
328
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
697
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
460
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.6K